6 Einträge gefunden

1. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

   1. Marx, Andreas
   2. Koopmann, Lena
   3. Höflmayer, Doris
   4. Büscheck, Franziska
   5. Hube-Magg, Claudia
   6. Steurer, Stefan
   7. Eichenauer, Till

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
3. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
4. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
5. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

   1. Steurer, Stefan
   2. Schwemmer, Lara
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Tsourlakis, Maria Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
6. Random forest-based modelling to detect biomarkers for prostate cancer progression

   1. Toth, Reka
   2. Schiffmann, Heiko
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Weidemann, Sören
   7. Lebok, Patrick

   2019 - Forschungsinformationssystem des UKE - frei zugänglich